[VRTX] YoY Quarter Result on 31-Mar-2023 [#Q1]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
02-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -14.54%
YoY- -8.17%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 2,687,200 2,374,800 2,097,500 1,724,305 1,515,107 858,435 640,799 26.96%
PBT 1,279,100 891,500 954,800 820,960 657,534 320,165 214,642 34.61%
Tax 179,500 191,700 192,700 167,822 54,781 51,534 -12,659 -
NP 1,099,600 699,800 762,100 653,138 602,753 268,631 210,263 31.71%
Tax Rate -14.03% -21.50% -20.18% -20.44% -8.33% -16.10% 5.90% -
Total Cost 1,587,600 1,675,000 1,335,400 1,071,167 912,354 589,804 430,536 24.27%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin 40.92 29.47 36.33 37.88 39.78 31.29 32.81 3.74%
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS 4.26 2.72 2.99 2.52 2.32 1.05 0.83 31.30%
EPS Diluted 4.21 2.69 2.96 2.49 2.29 1.03 0.81 31.58%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.